News
-
The UK Medicines and Healthcare Products Regulatory Agency has approved a Clinical Trial Application filed by Pulmatrix for a Phase 1/1b study of Pulmazole (PUR1900) inhaled dry powder itraconazole for the treatment of allergic bronchopulmonary… Read more . . .
-
Smartinhaler maker Adherium has opened a new corporate headquarters in San Mateo, California, the company said. In 2017, the company announced that it had sold more than 100,000 Smartinhaler inhaler monitoring systems. Adherium CEO Arik… Read more . . .
-
Copley Scientific has announced the launch of the BAC 2100 Breath Actuation Controller for automated flow control during cascade impaction and delivered dose uniformity testing of metered dose inhalers. The company is also launching the… Read more . . .
-
Copenhagen, Denmark — We are working with a joint venture created by one of the world’s largest designers and manufacturers of advanced drug delivery systems for the pharmaceutical & biotech markets and a leading global… Read more . . .
-
Spyryx Biosciences, which recently initiated a Phase 2 study of its SPX-101 inhaled SPLUNC1-derived peptide for the treatment of cystic fibrosis, announced that former United Therapeutics CEO Roger Jeffs has joined its board of directors.… Read more . . .
-
3P innovation, which recently launched a new robotic filling machine capable of filling inhalers as well as capsules, says that it has started work on a new facility at Tournament Fields near Warwick, UK. The… Read more . . .
-
Aradigm Corporation said that the FDA’s Antimicrobial Drugs Advisory Committee (ADAC) has voted against approval of the company’s NDA for Linhaliq dual release inhaled ciprofloxacin for the treatment of P. aeruginosa lung infections in non-cystic… Read more . . .
-
Eurocine Vaccines has received authorization from the Swedish Medical Products Agency for a Phase 1/2 clinical study of its intranasal quadrivalent influenza vaccine Immunose Flu during the current flu season, the company said. Eurocine Vaccines… Read more . . .
-
Boehringer Ingelheim announced that its Respimat soft mist inhaler has received an Ease of Use Commendation from the Arthritis Foundation. In order to receive the commendation, products submitted by manufacturers to the Arthritis Foundation for… Read more . . .
-
Functional respiratory imaging specialist FLUIDDA has announced a new research collaboration with a team at the University of California, San Francisco led by Professor John Fahy that will use FLUIDDA technology “to understand the effects… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA